Lee HJ, Kim YN, Jang HW, Jeon HH, Jung ES, Park SJ, Hong SP, Kim TI, Kim WH, Nam CM, Cheon JH. Correlations between endoscopic and clinical disease activity indices in intestinal Behcet's disease. World J Gastroenterol 2012; 18(40): 5771-5778 [PMID: 23155319 DOI: 10.3748/wjg.v18.i40.5771]
Corresponding Author of This Article
Jae Hee Cheon, MD, PhD, Division of Gastroenterology, Department of Internal Medicine, Institute of Gastroenterology, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul 120-752, South Korea. geniushee@yuhs.ac
Article-Type of This Article
Brief Article
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastroenterol. Oct 28, 2012; 18(40): 5771-5778 Published online Oct 28, 2012. doi: 10.3748/wjg.v18.i40.5771
Table 1 Baseline clinical characteristics of patients with intestinal Behcet’s disease
Characteristic
No. of patient (%)
Age at diagnosis of BD (yr)
38.5 ± 12.2
Age at diagnosis of intestinal BD (yr)
41.4 ± 12.3
Gender (male:female)
71:96 (42.5:57.5)
Systemic symptoms and signs of BD
Recurrent oral ulcer
159 (95.2)
Recurrent genital ulcer
78 (46.7)
Ocular lesion
10 (6.0)
Skin lesion
82 (49.1)
Positive pathergy test
4 (2.4)
Arthritis or arthralgia
66 (39.5)
Neurologic lesion
0
Vascular lesion
2 (1.2)
Clinical subtype of BD
Complete
3 (1.8)
Incomplete
78 (46.7)
Suspected
53 (31.7)
Symptoms and signs of intestinal involvement
Abdominal pain
120 (71.8)
Diarrhea
142 (85.0)
Abdominal mass
4 (2.4)
Tenderness
119 (71.2)
Nausea/vomiting
4 (2.4)
Melena/hematochezia
31 (18.6)
Fistula
4 (2.4)
Stenosis (intestinal obstruction)
10 (6.0)
Abscess
0
Perforation
0
Current use of medication
5-ASA or sulfasalazine
163 (97.6)
Azathioprine or 6-mercaptopurine
24 (14.4)
Colchicine
80 (47.9)
Corticosteroid
72 (43.1)
Patient global assessment
Well
63 (37.7)
Mild
53 (31.7)
Moderate
45 (26.9)
Severe
6 (3.6)
DAIBD
74.9 ± 36.1 (5-155)
Quiescent ( ≤ 19)
2 (1.2)
Mild (20-39)
32 (19.2)
Moderate (40-74)
50 (29.9)
Severe (≥ 75)
83 (49.7)
Table 2 Baseline colonoscopic characteristics of patients with intestinal Behcet’s disease
Characteristic
No. of patient (%)
Location of intestinal lesion
4 (2.4)
Ileal area
156 (93.4)
Ileocecal area
25 (15.0)
Ascending colon
18 (10.8)
Other colonic segment
Distribution of intestinal lesion
Localized involvement
142 (85.0)
Diffuse involvement
25 (15.0)
Number of intestinal ulcer
Solitary
86 (51.5)
2-5
53 (31.7)
≥ 5
28 (16.8)
Depth of intestinal ulcer
Aphthous
12 (7.2)
Shallow
46 (27.5)
Deep
109 (65.3)
Shape of intestinal ulcer
Oval
79 (47.3)
Geographic
52 (31.1)
Volcano
36 (21.6)
Size of intestinal ulcer (mm)
< 5
11 (6.6)
5-10
29 (17.4)
10-20
45 (26.9)
≥ 20
82 (49.1)
Margin of intestinal ulcer
Discrete
75 (44.9)
Elevation
13 (7.8)
Nodular elevation
32 (19.2)
Marginal erythema
47 (28.1)
Type of intestinal ulcer
Typical type
94 (56.3)
Atypical type
73 (43.7)
Diagnostic criteria of intestinal BD
Definite
69 (41.3)
Probable
82 (49.1)
Suspected
16 (9.6)
Table 3 Univariate analysis of endoscopic factors associated with the disease activity index for intestinal Behcet’s disease
Endoscopic factor
DAIBD (mean ± SD)
F/t value
P value
Location
0.48
0.632
Ileocecal area
74.58 ± 36.74
Other
80.00 ± 26.08
Distribution
Localized
73.98 ± 35.22
-0.82
0.414
Diffuse
80.40 ± 41.10
Number of intestinal ulcer
0.39
0.679
Solitary
72.67 ± 30.92
2- 5
76.51 ± 41.75
≥ 5
78.93 ± 40.08
Depth of intestinal ulcer
5.03
0.008
Aphthous
57.08 ± 37.02
Shallow
65.00 ± 30.09
Deep
81.10 ± 37.01
Shape of intestinal ulcer
13.33
< 0.001
Oval
65.13 ± 37.79
Geographic
72.60 ± 28.40
Volcano
99.86 ± 30.95
Size of intestinal ulcer (mm)
6.62
< 0.001
< 5
52.73 ± 35.45
5-10
69.48 ± 36.38
10-20
63.00 ± 33.02
≥ 20
86.40 ± 34.29
Margin of intestinal ulcer
1.95
0.124
Discrete
80.47 ± 37.70
Elevation
56.54 ± 33.63
Nodular elevation
75.47 ± 29.93
Marginal erythema
70.85 ± 36.81
Table 4 Multivariate analysis of endoscopic factors associated with the disease activity index for intestinal Behcet’s disease
Endoscopic factor
βcoefficient
P value
Intercept
47.44
Location
Ileocecal area
0
Other
9.04
0.389
Number of intestinal ulcer
Solitary
0
≥ 2
11.85
0.031
Depth of intestinal ulcer
Aphthous
0
Shallow
5.03
0.651
Deep
12.76
0.261
Shape of intestinal ulcer
Oval
0
Geographic
4.47
0.495
Volcano
26.93
0.001
Size of intestinal ulcer (mm)
< 20
0
≥ 20
8.65
0.225
Table 5 Predicted and actual disease activity index for intestinal Behcet’s disease scores in intestinal Behcet’s disease patients
Actual DAIBD
Predicted DAIBD by an endoscopic model
Total
Quiescent ( ≤19)
Mild (20-39)
Moderate (40-74)
Severe (≥75)
Quiescent ( ≤ 19)
0
0
1
1
2
Mild (20-39)
0
0
28
4
32
Moderate (40-74)
0
0
37
13
50
Severe (≥ 75)
0
0
42
41
83
Total
0
0
108
59
167
Citation: Lee HJ, Kim YN, Jang HW, Jeon HH, Jung ES, Park SJ, Hong SP, Kim TI, Kim WH, Nam CM, Cheon JH. Correlations between endoscopic and clinical disease activity indices in intestinal Behcet's disease. World J Gastroenterol 2012; 18(40): 5771-5778